Elevated C-reactive protein and white blood cell count at admission predict functional outcome after non-aneurysmal subarachnoid hemorrhage
- 73 Downloads
Patients with non-aneurysmal subarachnoid hemorrhage (SAH) are considered to have an overall benign course of disease compared to patients suffering from aneurysmal SAH. Nevertheless, a small but significant number of such patients might only achieve unfavorable outcome. Therefore, the purpose of the present study was to determine if routine laboratory markers of acute phase response are associated with unfavorable outcome in patients with non-aneurysmal SAH.
From 2006 to 2017, 154 patients suffering from non-aneurysmal SAH were admitted to our institution. Patients were stratified according to the distribution of cisternal blood into patients with perimesencephalic SAH (pSAH) versus non-perimesencephalic SAH (npSAH). C-reactive protein (CRP) and white blood cells (WBC) assessments were performed within 24 h of admission as part of routine laboratory workup. Outcome was assessed according to the modified Rankin Scale (mRS) after 6 months and stratified into favorable (mRS 0–2) vs. unfavorable (mRS 3–6).
The multivariate regression analysis revealed “CRP > 5 mg/l” (p = 0.004, OR 143.7), “WBC count > 12.1 G/l” (p = 0.006, OR 47.8), “presence of IVH” (p = 0.02, OR 13.5), “poor-grade SAH” (p = 0.01, OR 45.2) and “presence of CVS” (p = 0.003, OR 149.9) as independently associated with unfavorable outcome in patients with non-aneurysmal SAH.
Elevated C-reactive protein and WBC count at admission were associated with unfavorable outcome after non-aneurysmal SAH.
KeywordsNon-aneurysmal subarachnoid hemorrhage Outcome Perimesencephalic C-reactive protein
Compliance with ethical standards
Conflicts of interest
The authors declare that they have no conflicts of interest.
The present study was approved by the local ethics committee.
Informed consent was not sought as a retrospective study design was used.
- 3.Schuss P, Hadjiathanasiou A, Brandecker S, Wispel C, Borger V, Güresir Á, Vatter H, Güresir E (2018) Risk factors for shunt dependency in patients suffering from spontaneous, non-aneurysmal subarachnoid hemorrhage. Neurosurg Rev. https://doi.org/10.1007/s10143-018-0970-0. CrossRefPubMedGoogle Scholar
- 7.Konczalla J, Kashefiolasl S, Brawanski N, Lescher S, Senft C, Platz J, Seifert V (2016) Cerebral vasospasm and delayed cerebral infarctions in 225 patients with non-aneurysmal subarachnoid hemorrhage: the underestimated risk of fisher 3 blood distribution. J Neurointerventional Surg 8(12):1247–1252CrossRefGoogle Scholar
- 9.Al-Mufti F, Merkler AE, Boehme AK, Dancour E, May T, Schmidt JM, Park S, Connolly ES, Lavine SD, Meyers PM, Claassen J, Agarwal S (2018) Functional outcomes and delayed cerebral ischemia following nonperimesencephalic angiogram-negative subarachnoid hemorrhage similar to aneurysmal subarachnoid hemorrhage. Neurosurgery 82(3):359–364CrossRefGoogle Scholar
- 11.Al-Mufti F, Misiolek KA, Roh D, Alawi A, Bauerschmidt A, Park S, Agarwal S, Meyers PM, Connolly ES, Claassen J, Schmidt JM (2018) White blood cell count improves prediction of delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage. Neurosurgery. https://doi.org/10.1093/neuros/nyy045 CrossRefPubMedGoogle Scholar
- 17.Konczalla J, Schuss P, Platz J, Vatter H, Seifert V, Güresir E (2015) Clinical outcome and prognostic factors of patients with angiogram-negative and non-perimesencephalic subarachnoid hemorrhage: benign prognosis like perimesencephalic sah or same risk as aneurysmal sah? Neurosurg Rev 38(1):121–127 (discussion 127) CrossRefGoogle Scholar
- 22.Tam AK, Ilodigwe D, Mocco J, Mayer S, Kassell N, Ruefenacht D, Schmiedek P, Weidauer S, Pasqualin A, Macdonald RL (2010) Impact of systemic inflammatory response syndrome on vasospasm, cerebral infarction, and outcome after subarachnoid hemorrhage: Exploratory analysis of conscious-1 database. Neurocritical Care 13(2):182–189CrossRefGoogle Scholar
- 25.Turner CL, Budohoski K, Smith C, Hutchinson PJ, Kirkpatrick PJ, Murray GD, collaborators S (2015) Elevated baseline c-reactive protein as a predictor of outcome after aneurysmal subarachnoid hemorrhage: data from the simvastatin in aneurysmal subarachnoid hemorrhage (STASH) trial. Neurosurgery 77(5):786–792; (discussion 792–783) CrossRefGoogle Scholar